Neuropsychiatry's Role in the Postacute Sequelae of COVID-19: Report From the American Neuropsychiatric Association Committee on Research.

Baslet, Gaston; Aybek, Selma; Ducharme, Simon; Modirrousta, Mandana; Nicholson, Timothy R (2022). Neuropsychiatry's Role in the Postacute Sequelae of COVID-19: Report From the American Neuropsychiatric Association Committee on Research. The journal of neuropsychiatry and clinical neurosciences, 34(4), pp. 341-350. American Psychiatric Association 10.1176/appi.neuropsych.21080209

Full text not available from this repository. (Request a copy)

The postacute sequelae of COVID-19 infection (PASC), also known as post-COVID condition or "long COVID," refers to symptoms that persist after the initial acute phase of the infection. PASC symptoms may occur in patients who had mild acute disease. On the basis of current data, commonly reported neurological and psychiatric symptoms in PASC include sleep problems, fatigue, cognitive impairment, headache, sensorimotor symptoms, dizziness, anxiety, irritability, and depression. Knowledge from neuropsychiatric sequelae of other viral infections, such as other coronaviruses, provides us with information about the heterogeneity and similarities of neuropsychiatric clinical presentations that may follow viral illnesses over a long period. Several, possibly overlapping, pathophysiological mechanisms have been proposed to explain neuropsychiatric PASC: direct effects of the virus and immunological, vascular, functional, iatrogenic, and other etiologies. The authors present practice considerations for clinicians confronted with the challenge of evaluating and treating patients who have neuropsychiatric PASC. A comprehensive neuropsychiatric approach reviews historical factors, provides an objective assessment of symptoms, carefully considers all potential etiologies, and offers a therapeutic approach aimed at restoring premorbid functioning. Given the currently limited therapeutic options for neuropsychiatric PASC, unless an alternative etiology is identified, treatment should be symptom based and guided by evidence as it emerges.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Aybek Rusca, Selma

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1545-7222

Publisher:

American Psychiatric Association

Language:

English

Submitter:

Pubmed Import

Date Deposited:

18 May 2022 13:52

Last Modified:

12 Jun 2023 08:22

Publisher DOI:

10.1176/appi.neuropsych.21080209

PubMed ID:

35578802

Uncontrolled Keywords:

COVID-19 Infectious Disease Long COVID Neuropsychiatric Assessment PASC (Post-acute Sequelae of COVID-19)

URI:

https://boris.unibe.ch/id/eprint/170097

Actions (login required)

Edit item Edit item
Provide Feedback